You are here

  • Home
  • Archive
  • Volume 14, Issue 3
  • In people with poorly controlled type 1 diabetes, cognitive behaviour therapy combined with motivational enhancement therapy reduces HbA1c after 12 months

Article Text

Article menu
Download PDFPDF
Adult nursing
Randomised controlled trial
In people with poorly controlled type 1 diabetes, cognitive behaviour therapy combined with motivational enhancement therapy reduces HbA1c after 12 months
  1. Leah Brennan
  1. Centre for Obesity Research and Education, Monash University, Victoria, Melbourne, Australia
  1. Correspondence to Leah Brennan
    Level 6, The Alfred Centre, 99 Commercial Road, Melbourne, VIC 3004, Australia; leah.brennan{at}monash.edu

https://doi.org/10.1136/ebn1164

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Ismail K, Maissi E, Thomas S, et al. A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study. Health Technol Assess 2010;14:1–101, iii–iv.OpenUrlPubMedWeb of Science

    Implications for practice

    • ▪ Motivational enhancement therapy (MET) +cognitive–behavioural therapy (CBT) can improve 12-month glycaemic control in adults with poorly controlled type 1 diabetes and is more effective than MET alone or usual care (UC).

    • ▪ MET+CBT and MET do not result in better quality of life, depression, body mass index or diabetes self-care activities.

    • ▪ With extensive training and supervision, nurses can be trained to deliver diabetes-specific MET and CBT.

    • ▪ Cost-effectiveness was not demonstrated.

    Implications for research

    Further research is required to determine:

    • ▪ active components of combined MET+CBT and patient's perceptions;

    • ▪ maintenance of MET+CBT effects over time;

    • ▪ use of MET+CBT in a variety of formats (eg, group, online).

    Context

    Type 1 diabetes is associated with a range of biopsychosocial consequences.1 Treatment …

    View Full Text

    Footnotes

    • Competing interests None.